C84 C91.5 C91.6 C86
Conditions
Interventions
Group 1: Patients aged > 18 years with a diagnosis of peripheral T-cell lymphoma (PTCL) (ICD-10 codes - C84.0-C84.9
C86.0-C86.6
C91.50 and C91.51
C91.60 and C91.61) registered from 01/2004 to 10/2025 at the University Hospital Essen.
Sponsors
Universitätsklinikum Essen
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients with aggressive mature T-NHL treated at university hospital Essen between 2004 to 2025
Exclusion criteria
Exclusion criteria: Age < 18 years Premature T-NHL, primary cutaneous or non-aggressive T-NHL
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Analysis of Overall survival (OS) ans progression free survival (PFS) of the whole study population. Single time analysis at the end of data collection. | — |
Secondary
| Measure | Time frame |
|---|---|
| Comparison of OS and PFS in patients with an without stem cell therapy (autologous or allogenic). OS and non-relaps.mortylity (NRM) in the study population that received a stem cell transplantation in first or second treatment line. | — |
Countries
Germany
Contacts
Public ContactKai Arne Plümer
Universitätsklinikum Essen
Outcome results
None listed